IMMUNOPHAGE Trademark

Trademark Overview

On Thursday, April 30, 2020, a trademark application was filed for IMMUNOPHAGE with the United States Patent and Trademark Office. The USPTO has given the IMMUNOPHAGE trademark a serial number of 88896315. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 19, 2022. This trademark is owned by PPI Holdings, Inc. The IMMUNOPHAGE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for treating cancer and infectious diseases; Pharmaceuticals for treating cancer and infectious diseases; immuno-oncology pharmaceuticals and therapeutics; pharmaceuticals and therapeutics that teach the immune system to recognize cancer and infectious diseases
immunophage

General Information

Serial Number88896315
Word MarkIMMUNOPHAGE
Filing DateThursday, April 30, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 19, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 23, 2021

Trademark Statements

Goods and ServicesVaccines for treating cancer and infectious diseases; Pharmaceuticals for treating cancer and infectious diseases; immuno-oncology pharmaceuticals and therapeutics; pharmaceuticals and therapeutics that teach the immune system to recognize cancer and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePPI Holdings, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NamePPI Holdings, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20879

Trademark Events

Event DateEvent Description
Monday, December 19, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 19, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 17, 2022SOU EXTENSION 2 GRANTED
Tuesday, May 17, 2022SOU EXTENSION 2 FILED
Tuesday, May 17, 2022TEAS EXTENSION RECEIVED
Saturday, May 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 27, 2021SOU EXTENSION 1 GRANTED
Thursday, May 27, 2021SOU EXTENSION 1 FILED
Thursday, May 27, 2021TEAS EXTENSION RECEIVED
Tuesday, May 18, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 27, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 27, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 27, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 27, 2020NON-FINAL ACTION E-MAILED
Monday, July 27, 2020NON-FINAL ACTION WRITTEN
Friday, July 24, 2020ASSIGNED TO EXAMINER
Sunday, July 5, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, July 5, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, July 5, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 4, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

immunophage pharmaceuticals infectious diseases cancer therapeutics treating immune system recognize immuno